Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2007-06-12
2007-06-12
Ungar, Susan (Department: 1642)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
Reexamination Certificate
active
10723383
ABSTRACT:
Anti-DR4 or Anti-DR5 antibody agonists, combined with apoptosis-inducing agents, synergistically induce apoptosis in cancer cells.
REFERENCES:
Ichikawa et al. (2001, Nature Medicine 7(8):954-960).
Kipriyanov (1999, Molecular Biotechnology 12:173-201).
Bowie et al, Science, 247:1306-1310, 1990.
Gussow et al (Methods in Enzymology, 1991, 203:99-121).
Rudikoff et al, PNAS, USA, 1982, 79: 1979-1983.
Chuntharapai, Anan et al.; “Isotype-Dependent Inhibition of Tumor Growth In Vivo by Monoclonal Antibodies to Death Receptor 4”;The Journal of Immunology, vol. 166, pp. 4891-4898.
Dong, Qiang G. et al.; “The function of multiple IkB: NF-kB complexes in the resistance of cancer cells to Taxol-induced apoptosis”; 2002,Oncogene, vol. 21, pp. 6510-6519.
Odoux, Christine et al.; “Trail, Fast and a Blocking Anti-DR5 Antibody Augment Paclitaxel-Induced Apoptosis in Human Non-Small-Cell”; 2002,Int. J. Cancer, vol. 97, pp. 458-465.
Aza-Blanc Pedro
Deveraux Quinn L.
Hampton Garret M.
Knee Deborah A.
Nasoff Marc
IRM LLC
Joyce Catherine
Townsend and Townsend / and Crew LLP
Ungar Susan
LandOfFree
Methods and compositions for inducing apoptosis in cancer cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for inducing apoptosis in cancer cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for inducing apoptosis in cancer cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3814780